Madrigal Pharmaceuticals (MDGL) Q2 2026 Earnings

12MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-5.08
-3.69
-2.29
-0.9

Details

Expected EPS
-4.266595
Actual EPS
N/A
Surprise EPS
4.27
Surprise Percent
+100%

Description

Madrigal Pharmaceuticals (MDGL) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts